Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Role of hematopoietic stem cell transplantation for relapsed acute promyelocytic leukemia: A retrospective analysis of JALSG ‐ APL 97
Ist Teil von
Cancer science, 2013-10, Vol.104 (10), p.1339-1345
Erscheinungsjahr
2013
Quelle
Wiley Backfiles (~2019)
Beschreibungen/Notizen
For patients with relapsed acute promyelocytic leukemia (
APL
), all
‐trans
retinoic acid‐based salvage regimens can achieve second complete remission (
CR
2), but the optimal post‐remission strategy for
APL
patients after
CR
2 remains unclear. Hematopoietic stem cell transplantation (
HSCT
) during
CR
2 might be effective, but data on the role of
HSCT
for
APL
patients after
CR
2 are limited in
J
apan. We retrospectively analyzed outcomes for 57 relapsed
APL
patients who achieved
CR
2 in the
JALSG APL
97 study. Of those, six received autologous (auto)‐
HSCT
, 21 received allogeneic (allo)‐
HSCT
, and 30 received various regimens other than
HSCT
. The 5‐year event‐free survival (
EFS
) rate, overall survival (OS) rate and cumulative incidence of relapse (
CIR
) were 50.7%, 77.4% and 51.0% in the non‐
HSCT
group, 41.7%, 83.3% and 58.3% in the auto‐
HSCT
group and 71.1%, 76.2% and 9.8% in the allo‐
HSCT
group, respectively. Both the
EFS
rate and
CIR
were significantly better in the allo‐
HSCT
group than in other groups. Allo‐
HSCT
appears effective in
APL
patients in
CR
2, with a low relapse rate beyond a relatively early transplantation‐related mortality (19%). Among older patients (age ≥40 years), the 5‐year
OS
was significantly better in the non‐
HSCT
group than in the
HSCT
group (78.0%
vs
40.5%;
P
= 0.04). Further prospective studies with larger patient numbers are required to confirm the impact of
HSCT
alone and in combination with arsenic trioxide on outcomes for patients with
APL
in
CR
2.
Sprache
Englisch
Identifikatoren
ISSN: 1347-9032
eISSN: 1349-7006
DOI: 10.1111/cas.12230
Titel-ID: cdi_crossref_primary_10_1111_cas_12230
Format
–
Weiterführende Literatur
Empfehlungen zum selben Thema automatisch vorgeschlagen von bX